Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy of radiofrequency ablation of hepatocellular carcinoma prior to liver transplantation and the need for competing-risk analysis.

Literature DB >> 30221158

Efficacy of radiofrequency ablation of hepatocellular carcinoma prior to liver transplantation and the need for competing-risk analysis.

Alessandro Cucchetti¹, Matteo Serenari¹.

Abstract

Entities: Disease

Year: 2018 PMID： 30221158 PMCID： PMC6131260 DOI： 10.21037/hbsn.2018.04.05

Source DB: PubMed Journal: Hepatobiliary Surg Nutr ISSN： 2304-3881 Impact factor: 7.293

× No keyword cloud information.

13 in total

1. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.

Authors: Alessandro Cucchetti; Matteo Cescon; Eleonora Bigonzi; Fabio Piscaglia; Rita Golfieri; Giorgio Ercolani; Maria Cristina Morelli; Matteo Ravaioli; Antonio Daniele Pinna
Journal: Liver Transpl Date: 2011-11 Impact factor: 5.799

2. When do we need competing risks methods for survival analysis in nephrology?

Authors: Marlies Noordzij; Karen Leffondré; Karlijn J van Stralen; Carmine Zoccali; Friedo W Dekker; Kitty J Jager
Journal: Nephrol Dial Transplant Date: 2013-08-24 Impact factor: 5.992

3. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.

Authors: Julius Chapiro; Laura D Wood; MingDe Lin; Rafael Duran; Toby Cornish; David Lesage; Vivek Charu; Rüdiger Schernthaner; Zhijun Wang; Vania Tacher; Lynn Jeanette Savic; Ihab R Kamel; Jean-François Geschwind
Journal: Radiology Date: 2014-07-15 Impact factor: 11.105

4. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Authors: Christoph Wald; Mark W Russo; Julie K Heimbach; Hero K Hussain; Elizabeth A Pomfret; Jordi Bruix
Journal: Radiology Date: 2013-02 Impact factor: 11.105

5. Deaths on the liver transplant waiting list: an analysis of competing risks.

Authors: W Ray Kim; Terry M Therneau; Joanne T Benson; Walter K Kremers; Charles B Rosen; Gregory J Gores; E Rolland Dickson
Journal: Hepatology Date: 2006-02 Impact factor: 17.425

6. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.

Authors: Min Woo Lee; Steven S Raman; Nazanin H Asvadi; Surachate Siripongsakun; Robert M Hicks; Jeffrey Chen; Akeanong Worakitsitisatorn; Justin McWilliams; Myron J Tong; Richard S Finn; Vatche G Agopian; Ronald W Busuttil; David S K Lu
Journal: Hepatology Date: 2017-04-28 Impact factor: 17.425

7. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.

Authors: Lorenzo Mannelli; Sooah Kim; Cristina H Hajdu; James S Babb; Timothy W I Clark; Bachir Taouli
Journal: AJR Am J Roentgenol Date: 2009-10 Impact factor: 3.959

Review 8. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.

Authors: Matteo Cescon; Alessandro Cucchetti; Matteo Ravaioli; Antonio Daniele Pinna
Journal: J Hepatol Date: 2012-10-04 Impact factor: 25.083